The global cancer microbiome sequencing market is projected to reach $1,216.2 million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 20.01% between 2021 and 2031. The comprehensive study of the global cancer microbiome sequencing market by BIS Research extensively covers the following: • Market numbers on micro-segments that are influencing the market • More than 100 products present in the mark...